Assessment of former and newly developed HBV assays in a third world settingZABALETA, M. E; TORO, F. I; RUIZ, M. E et al.Journal of medical virology. 1992, Vol 38, Num 4, pp 240-245, issn 0146-6615Article

CD3- and CD28-activating pathways in HCV infectionCORADO, J. A; TORO, F. I; BAROJA, M. L et al.Viral immunology. 1994, Vol 7, Num 1, pp 37-40, issn 0882-8245Article

Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsBAROJA, M. L; SIRIT, F. L; CALDERA, D. J et al.Clinical immunology and immunopathology (Print). 1993, Vol 69, Num 2, pp 180-188, issn 0090-1229Article